Why the study?
Does recombinant human antithrombin prevent venous thromboembolism in pregnant patients with hereditary antithrombin deficiency?
Does recombinant human antithrombin prevent venous thromboembolism in pregnant patients with hereditary antithrombin deficiency?
Recombinant human antithrombin is safe and effective for preventing peripartum VTE in pregnant patients with hereditary antithrombin deficiency.
No takes yet. Share an insight, caveat, or question.
Supports rhAT for peripartum VTE prevention in hereditary AT deficiency; confirms efficacy in Level 1 meta-analysis.
Triche et al. (2015) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: